Resources

Explore Additional Resources

Explore resources by selecting a category of your choice

Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 Influenza viruses

Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 Influenza viruses

April 1, 2017

Categories: mRNA Vaccines, Global Health, Preclinical, Clinical

Journal Article

View resource
View resource
Modified mRNA vaccines protect against Zika virus infection

Modified mRNA vaccines protect against Zika virus infection

February 1, 2017

Categories: mRNA Vaccines, Global Health, Preclinical

Journal Article

View resource
View resource
Preclinical and clinical demonstration of immunogenicity

Preclinical and clinical demonstration of immunogenicity

April 1, 2017

Categories: mRNA Vaccines, Global Health, Preclinical, Clinical

Journal Article

View resource
View resource
Vaccine mediated protection against Zika virus-induced congenital disease

Vaccine mediated protection against Zika virus-induced congenital disease

July 1, 2017

Categories: mRNA Vaccines, Global Health, Preclinical

Journal Article

View resource
View resource
Efficient Targeting and Activation of Antigen Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques

Efficient Targeting and Activation of Antigen Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques

August 1, 2017

Categories: mRNA Vaccines, Delivery Science, Preclinical

Journal Article

View resource
View resource
Rhesus Macaque Myeloid-Derived Suppressor Cells Demonstrate T Cell Inhibitory Functions and Are Transiently Increased after Vaccination

Rhesus Macaque Myeloid-Derived Suppressor Cells Demonstrate T Cell Inhibitory Functions and Are Transiently Increased after Vaccination

November 17, 2017

Categories: mRNA Vaccines, Preclinical

Journal Article

View resource
View resource
Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells

Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells

November 1, 2017

Categories: mRNA Vaccines, Global Health, Preclinical

Journal Article

View resource
View resource
Multi-antigenic, pentamer-based, human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity

Multi-antigenic, pentamer-based, human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity

February 1, 2018

Categories: mRNA Vaccines, Preclinical

Journal Article

View resource
View resource
Tetravalent Immunogen Assembled from Conserved Regions of HIV-1 and Delivered as mRNA Demonstrates Potent Preclinical T-Cell Immunogenicity and Breadth

Tetravalent Immunogen Assembled from Conserved Regions of HIV-1 and Delivered as mRNA Demonstrates Potent Preclinical T-Cell Immunogenicity and Breadth

July 1, 2020

Categories: mRNA Vaccines, Global Health, Preclinical

Journal Article

View resource
View resource

Interested in mRNA Access?

Partner with us to bring this global health initiative to life.

By submitting your information, you agree to Moderna's Terms and Conditions. You also acknowledge that your information will be processed in accordance with Moderna's Privacy Policy.

To help protect this form from spam and abuse, Moderna uses automated security controls.